Tele-Navigation of Lung Cancer Screening (Tele-Navi LCS)

Completed · Not applicable

Conditions studied: Lung Cancer

In brief

Adherence to annual follow up is critical to achieving mortality benefits and optimizing cost-effectiveness of lung cancer screening (LCS). However, adherence to LCS follow-up in the real world is suboptimal. Using telehealth, the investigators will co-create Tele-Navigation of Lung Cancer Screening with patients and LCS stakeholders as an intervention to promote adherence of follow-up LCS. The investigators will then implement the Tele-Navi LCS intervention to a pilot sample of patients and evaluate its feasibility in the primary care setting. The investigators will measure the number of patient participants who completed Tele-Navi LCS and follow-up LCS within 180 days from Tele-Navi LCS.

Key facts

Study ID

NCT05021133

Run by

University of Massachusetts, Worcester

People needed

22

Starts

2023-06-05

Expected to finish

2025-12-12

Last updated by the study team

2026-01-08

Who can join

Age: 50 and older, up to 77. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Is eligible for LDCT for LCS follow-up
• Has technology to complete study activities (e.g., video call visit)
• English speaker
• Has undergone LCS at UMMH
• Is overdue for LDCT follow-up

You may not qualify if…

• Has previous diagnosis of lung cancer
• Has active cancer diagnosis
• Is a nursing home or group care resident
• Is pregnant

Where it is running

• UMass Chan Medical School — Worcester, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.